Research Grant
[Cite as http://purl.org/au-research/grants/nhmrc/1026382]Researchers: Prof Clive Prestidge (Principal investigator) , Prof Ben Boyd , Prof Dorothy Keefe
Brief description Based on nanotechnology a new medicine will be developed for chemotherapy drugs. Drugs that are currently only delivered by injection will be able to be taken as an orally dosed tablet. A novel therapy for colorectal cancer will be advanced with potential improved clinical outcomes and reduced side-effects, e.g. nausea and diarrhoea. Cancer patients will no longer need to visit the hospital for injection therapy and therefore reducing the burden on the health service.
Funding Amount $AUD 560,072.79
Funding Scheme Project Grants
Notes Standard Project Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1026382
- nhmrc : 1026382